Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 20, 2014
[ Thu, Mar 20th 2014
] - WOPRAI
Wed, March 19, 2014
[ Wed, Mar 19th 2014
] - WOPRAI
[ Wed, Mar 19th 2014
] - WOPRAI
[ Wed, Mar 19th 2014
] - WOPRAI
[ Wed, Mar 19th 2014
] - WOPRAI
Tue, March 18, 2014
[ Tue, Mar 18th 2014
] - WOPRAI
[ Tue, Mar 18th 2014
] - WOPRAI
[ Tue, Mar 18th 2014
] - WOPRAI
Mon, March 17, 2014
[ Mon, Mar 17th 2014
] - WOPRAI
[ Mon, Mar 17th 2014
] - WOPRAI
Fri, March 14, 2014
[ Fri, Mar 14th 2014
] - WOPRAI
[ Fri, Mar 14th 2014
] - WOPRAI
[ Fri, Mar 14th 2014
] - WOPRAI
[ Fri, Mar 14th 2014
] - WOPRAI
[ Fri, Mar 14th 2014
] - WOPRAI
[ Fri, Mar 14th 2014
] - WOPRAI
Wed, March 12, 2014
[ Wed, Mar 12th 2014
] - WOPRAI
[ Wed, Mar 12th 2014
] - WOPRAI
Tue, March 11, 2014
[ Tue, Mar 11th 2014
] - WOPRAI
[ Tue, Mar 11th 2014
] - WOPRAI
[ Tue, Mar 11th 2014
] - WOPRAI
[ Tue, Mar 11th 2014
] - WOPRAI
Mon, March 10, 2014
[ Mon, Mar 10th 2014
] - WOPRAI
[ Mon, Mar 10th 2014
] - WOPRAI
[ Mon, Mar 10th 2014
] - WOPRAI
Andrew Fein Initiated (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014
Andrew Fein of HC Wainwright & Co., Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014.
Andrew has made no other calls on BCRX in the last 4 months.
There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Justin Kim of "Oppenheimer" Initiated at Hold on, Thursday, February 27th, 2014
This is the rating of the analyst that currently disagrees with Andrew
- Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Tuesday, January 28th, 2014
